Movano

Movano FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Movano (MOVE) as of Oct 27, 2026 is 61.62 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 95.00 % — a change of -35.13% (lower).

FCF Conversion

61.62 %

YoY

-35.13%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Movano is 2025 61.62 % . FCF Conversion Rate (FCF/EBITDA) of Movano was 2024 95.00 % . It decreases by -35.13% lower compared to the previous year.

The Movano FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
95.44 USD
Jan 1, 2019
97.64 USD
Jan 1, 2020
80.02 USD
Jan 1, 2021
74.17 USD
Jan 1, 2022
82.82 USD
Jan 1, 2023
89.61 USD
Jan 1, 2024
95.00 USD
Jan 1, 2025
61.62 USD
The Movano FCF Conversion history
YEARFCF ConversionYoY
61.62 %-35.13%
95.00 %+6.01%
89.61 %+8.21%
82.82 %+11.66%
74.17 %-7.32%
80.02 %-18.05%
97.64 %+2.31%
95.44 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Movano Stock analysis

What does Movano do? Movano, Inc. generates revenue through its Evie Ring, a women-focused wearable device that tracks health and wellness metrics including resting heart rate, heart rate variability, blood oxygen saturation, respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity metrics like steps and calories burned, sleep stages, and mood. The company also develops System-on-a-Chip (SoC) technology for blood pressure and continuous glucose monitoring systems, targeting medical device manufacturers. Its primary customers are health-conscious women seeking comprehensive wellness insights and medical device companies requiring specialized hardware components. Movano's revenue streams are derived from direct sales of the Evie Ring and licensing of its SoC technology to industry partners. The Evie Ring is designed specifically for women, integrating multiple health metrics into a single wearable, while the SoC technology serves as a foundational component for medical devices. Movano's product development focuses on health-focused technology, with the Evie Ring being its flagship consumer product and the SoC targeting the medical device sector. The company's business model centers on combining consumer health wearables with specialized hardware for medical applications, leveraging its expertise in health data integration. Movano is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Movano stock

FCF Conversion Rate (FCF/EBITDA) of Movano is 61.62 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Movano changed from 95.00 % to 61.62 %, representing a -35.13% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Movano since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Movano with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Movano

All Key Metrics — Movano